Article info

Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines

Authors

  1. Correspondence to Dr Rajeev Gupta, Stem Cell Laboratory, UCL Cancer Institute, London, UK; rajeev.gupta{at}ucl.ac.uk
View Full Text

Citation

Glynne P, Tahmasebi N, Gant V, et al
Long COVID following mild SARS-CoV-2 infection: characteristic T cell alterations and response to antihistamines

Publication history

  • Accepted August 25, 2021
  • First published October 5, 2021.
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.